Phase II, multicentre study evaluating cisplatin (P), epirubicin (E) and vinorelbine (V) as first line chemotherapy (CHT) in advanced breast cancer (ABC): A new promise
2004 ◽
Vol 22
(14_suppl)
◽
pp. 761-761
Keyword(s):
Phase Ii
◽